Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Intangibles (2016 - 2025)

Ekso Bionics Holdings (EKSO) has disclosed Intangibles for 9 consecutive years, with $4.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Intangibles changed N/A to $4.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.2 million, a N/A change, with the full-year FY2024 number at $5.2 million, up 6.7% from a year prior.
  • Intangibles was $4.2 million for Q3 2025 at Ekso Bionics Holdings, down from $5.2 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $5.2 million in Q2 2022 to a low of $4.2 million in Q3 2025.
  • A 4-year average of $5.0 million and a median of $5.1 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: decreased 6.23% in 2023, then grew 6.7% in 2024.
  • Ekso Bionics Holdings' Intangibles stood at $5.2 million in 2022, then dropped by 6.23% to $4.9 million in 2023, then increased by 6.7% to $5.2 million in 2024, then dropped by 20.46% to $4.2 million in 2025.
  • Per Business Quant, the three most recent readings for EKSO's Intangibles are $4.2 million (Q3 2025), $5.2 million (Q4 2024), and $4.9 million (Q4 2023).